Net profit of Beryl Drugs declined 30.19% to Rs 0.37 crore in the quarter ended June 2024 as against Rs 0.53 crore during the previous quarter ended June 2023. Sales declined 22.93% to Rs 6.25 crore in the quarter ended June 2024 as against Rs 8.11 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 6.25 | 8.11 | -23 |
| OPM % | 15.84 | 13.93 | - |
| PBDT | 0.78 | 1.01 | -23 |
| PBT | 0.50 | 0.73 | -32 |
| NP | 0.37 | 0.53 | -30 |